Johnson Financial Group Inc (Wisconsin)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Johnson Financial Group Inc (Wisconsin)'s MRNA Position: Q2 2026 in Review
Johnson Financial Group Inc (Wisconsin) sold out of Moderna (MRNA) in Q2 2026, closing a stake of 33 shares — an estimated $1.68K sold.
Johnson Financial Group Inc (Wisconsin) first reported a position in MRNA in Q2 2020 and held it in 8 quarters. The position peaked at $32K in Q4 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
- Johnson Financial Group Inc (Wisconsin) sold 33 Moderna shares in Q2 2026, an estimated $1.68K.
- Johnson Financial Group Inc (Wisconsin) first reported a position in Moderna in Q2 2020 and held it in 8 quarters.
- Johnson Financial Group Inc (Wisconsin)'s Moderna position peaked at $32K in Q4 2021.
- 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.